Company intelligence / Profile preview

Convergent Biomedical Group

Marlborough, Massachusetts, United States

Ownership: Private
Employees: ~7
Development stage: Other

Overview

Convergent Biomedical Group is a private U.S. life sciences and medical technology advisory company founded by James J. Barry, Ph.D. The firm appears to provide consulting and strategic advisory services to the medical device industry, life science companies, investors, and universities rather than developing its own therapeutic pipeline. Publicly available information indicates the company is based in Marlborough, Massachusetts and was formed in 2011. Available sources do not show an internal drug development portfolio, named clinical programs, or proprietary therapeutic assets. For a biotech analyst, the company is best characterized as a small healthcare-focused advisory business with medtech and commercialization expertise.

Industry: Consulting

Beyond the preview

Go deeper on Convergent Biomedical Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Convergent Biomedical Group.

Explore the full profile